ARBUTUS BIOPHARMA CORP's ticker is and the CUSIP is 03879J900. A total of 3 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $472,000 | +362.7% | 1,311 | +316.2% | 0.03% | +416.7% |
Q1 2017 | $102,000 | -79.5% | 315 | -84.5% | 0.01% | -79.3% |
Q4 2016 | $498,000 | -25.7% | 2,033 | +4.3% | 0.03% | +16.0% |
Q3 2016 | $670,000 | +187.6% | 1,949 | +191.3% | 0.02% | +108.3% |
Q2 2016 | $233,000 | -10.4% | 669 | +6.2% | 0.01% | -7.7% |
Q1 2016 | $260,000 | +66.7% | 630 | +79.5% | 0.01% | +44.4% |
Q4 2015 | $156,000 | -67.4% | 351 | -55.4% | 0.01% | -55.0% |
Q3 2015 | $479,000 | – | 787 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 276,600 | $644,478 | 0.00% |
SIMPLEX TRADING, LLC | 71,800 | $167 | 0.00% |
JANE STREET GROUP, LLC | 25,500 | $59,415 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |